Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Arterial Thromboembolism”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT01654042
What this trial is testing

Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II

Who this might be right for
Atrial FibrillationValvular Heart DiseaseDeep Vein Thrombosis+2 more
McMaster University
Early research (Phase 1)Study completedNCT06562985
What this trial is testing

Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years

Who this might be right for
Acute Venous and Arterial Thrombotic and Thromboembolic EventsHealthy Volunteers
Bayer 39
Not applicableStudy completedNCT04535128
What this trial is testing

COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications

Who this might be right for
Covid19Thrombosis EmbolismDVT+3 more
Brigham and Women's Hospital 11,000
Large-scale testing (Phase 3)Study completedNCT00786474
What this trial is testing

Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)

Who this might be right for
Arterial Thromboembolic EventsAtrial Fibrillation
Duke University 1,884
Not applicableLooking for participantsNCT05378035
What this trial is testing

DOAC in Chinese Patients With Atrial Fibrillation

Who this might be right for
Atrial FibrillationStrokeStroke, Acute+4 more
Chinese University of Hong Kong 427
Large-scale testing (Phase 3)UnknownNCT00222677
What this trial is testing

Aspirin for the Prevention of Recurrent Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism+1 more
University Of Perugia 70
Not applicableStudy completedNCT01113645
What this trial is testing

Impact of Cranioplasty On Cerebral Perfusion

Who this might be right for
Head InjuriesSubarachnoid HaemorrhageIntra-cerebral Haemorrhage+2 more
Assistance Publique - Hôpitaux de Paris 20
Not applicableUnknownNCT01558206
What this trial is testing

Ultrasonography of Chest Versus Pulmonary Artery CT Angiography in Patients With Symptoms and Signs in Favor of PTE

Who this might be right for
Pulmonary Thromboembolism
Isfahan University of Medical Sciences 76
Testing effectiveness (Phase 2)Study completedNCT02564718
What this trial is testing

Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates

Who this might be right for
Thromboembolism
Bayer 10
Not applicableLooking for participantsNCT06727669
What this trial is testing

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

Who this might be right for
Immune ThrombocytopeniaThrombotic Thrombocytopenic PurpuraHemophilia A, Acquired+13 more
Peking University People's Hospital 3,000
Large-scale testing (Phase 3)UnknownNCT00336596
What this trial is testing

Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion

Who this might be right for
Intracranial EmbolismThrombosis
University of Zurich 400
Early research (Phase 1)Study completedNCT01707394
What this trial is testing

Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder

Who this might be right for
Thromboembolism
Bristol-Myers Squibb 49
Not applicableLooking for participantsNCT07350499
What this trial is testing

Aspiration Thrombectomy Using the Symphony or Prodigy System

Who this might be right for
Arterial ThromboembolismVenous ThromboembolismPulmonary Embolism
Imperative Care, Inc. 750
Large-scale testing (Phase 3)Looking for participantsNCT07410117
What this trial is testing

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

Who this might be right for
Cancer-Associated Thrombosis (CAT)
Regeneron Pharmaceuticals 1,120
Large-scale testing (Phase 3)Ended earlyNCT00338585
What this trial is testing

Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery

Who this might be right for
Arterial Occlusive Diseases
ARCA Biopharma, Inc. 300
Post-approval studies (Phase 4)UnknownNCT00862160
What this trial is testing

Incidence of Acute Cerebrovascular Events Using Either Minimized or Standard Cardiopulmonary Bypass Circuit

Who this might be right for
Coronary Artery DiseaseAcute Cerebrovascular AccidentIntracranial Embolism+1 more
Hannover Medical School 64
Large-scale testing (Phase 3)Study completedNCT06825416
What this trial is testing

A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Who this might be right for
Prevention of Arterial and Venous Thrombosis
Beijing Suncadia Pharmaceuticals Co., Ltd 1,165
Not applicableStudy completedNCT04768036
What this trial is testing

A Universal Electronic Health Record-based IMPROVE DD VTE Risk Assessment Model for the Prevention of Thromboembolism in Hospitalized Medically Ill Patients

Who this might be right for
Venous ThromboembolismArterial Thromboembolism
Northwell Health 10,699
Not applicableStudy completedNCT01366599
What this trial is testing

CV Events in Emetogenic Chemotherapy

Who this might be right for
VomitingCardiovascular EventArterial Thromboembolic Event
GlaxoSmithKline 12,058
Large-scale testing (Phase 3)Study completedNCT00115999
What this trial is testing

Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries

Who this might be right for
Arterial Occlusive Diseases
ARCA Biopharma, Inc. 300
Next Page